Celogen Lifescience & Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-07-2024
- Paid Up Capital ₹ 0.10 M
as on 03-07-2024
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 60.86%
(FY 2023)
- Profit 210.14%
(FY 2023)
- Ebitda 9.23%
(FY 2023)
- Net Worth 10.60%
(FY 2023)
- Total Assets -8.20%
(FY 2023)
About Celogen Lifescience & Technologies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Rajan, Thykoottathil Matthews, Rabi Nayak, and One other member serve as directors at the Company.
- CIN/LLPIN
U73100MH2010PTC209971
- Company No.
209971
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 2010
- Date of AGM
17 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Celogen Lifescience & Technologies?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rabi Nayak  | Director | 11-Nov-2010 | Current |
| Amit Rajan | Director | 11-Nov-2010 | Current |
| Vijaykumar Nair | Director | 11-Nov-2010 | Current |
| Thykoottathil Matthews | Director | 11-Nov-2010 | Current |
Financial Performance of Celogen Lifescience & Technologies.
Celogen Lifescience & Technologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 60.86% increase. The company also saw a substantial improvement in profitability, with a 210.14% increase in profit. The company's net worth Soared by an impressive increase of 10.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Celogen Lifescience & Technologies?
In 2023, Celogen Lifescience & Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Celogen Pharma Private LimitedActive 19 years 9 monthsThykoottathil Matthews and Vijaykumar Nair are mutual person
Celogen Laboratories Private LimitedActive 12 years 11 monthsThykoottathil Matthews, Rabi Nayak and 1 more are mutual person
Gpax Pharmaceuticals Private LimitedActive 10 years 3 monthsAmit Rajan, Thykoottathil Matthews and 2 more are mutual person
- Agam And Gem Laboratories Private LimitedActive 29 years 26 days
Thykoottathil Matthews, Rabi Nayak and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Celogen Lifescience & Technologies?
Celogen Lifescience & Technologies has a workforce of 8 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Celogen Lifescience & Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Celogen Lifescience & Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
